Emma J. Birks, FRCP, PhD, Robert S

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Manuel J. Antunes, MD, PhD, DSc

HeartWare left ventricular assist device thrombosis including outflow graft Ioannis Dimarakis, PhD, MRCS, Steven Shaw, PhD, MRCP, Rajamiyer Venkateswaran,

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures J. Saravana Ganesh, FRCS, Chris.

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Intrinsic cardiac stem cells are essential for regeneration

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Form ever follows function

Victor van Berkel, MD, PhD

Totally thoracoscopic closure of ventricular septal defect without a robotically assisted surgical system: A summary of 119 cases Zeng-Shan Ma, MD, Chang-Yong.

William M. DeCampli, MD, PhD

Phil Botha, MRCS, Dipesh Trivedi, FRCS, Christopher J

Marye J. Gleva, MD, Charles B. Huddleston, MD

How should we treat air leaks?

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial Stacey.

Resuscitation practices in cardiac surgery

What is the best approach for surgery of malignant pleural mesothelioma? It is to put our efforts into obtaining trustworthy evidence for practice Tom.

Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C

Tomasz A. Timek, MD, Robert L

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Impact of prior hospital mortality versus surgical volume on mortality following surgery for congenital heart disease Matthew E. Oster, MD, Matthew J.

A technique for implanting outflow cannulas for Berlin Heart EXCOR ventricular assist device in small pediatric patients Khanh Nguyen, MD The Journal.

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Support Your Specialty

Bartley P. Griffith, MD, FACS, FRCS

A first start for lung transplantation?

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Surgical relief of left ventricular outflow obstruction in pediatric hypertrophic cardiomyopathy: The need for a tailored approach John M. Karamichalis,

Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011 William L.

Commentary: It's time to check our bias: Ensuring health equity for patients with lung cancer Pamela Samson, MD, MPHS The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

A fate worse than death Jennifer S. Lawton, MD

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

Biomaterials for heart valve replacement: Conjectures and refutations

Functional tricuspid pathology: To treat or not to treat

Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study Nicholas C. Dang,

The harder one looks, the more one finds

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices Forum Kamdar, MD, Ranjit John,

The continuing challenge of congenital heart disease in China

Cerebrovascular accidents in patients with a ventricular assist device

Optimal timing of cardiac transplantation after ventricular assist device implantation James S Gammie, MD, Leah B Edwards, PhD, Bartley P Griffith, MD,

Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.

Long-term results of heart transplantation in patients older than 60 years Philippe Demers, MD, MSc, FRCSC, Susan Moffatt, MD, PhD, FRCSC, Philip E Oyer,

“The more things change…”: The challenges ahead

Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence? Chase R. Brown, MD, Fabliha.

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

The Journal of Thoracic and Cardiovascular Surgery

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets Juan A. Crestanello, MD The Journal of Thoracic.

Perioperative monitoring in high-risk infants after stage 1 palliation of univentricular congenital heart disease Nancy S. Ghanayem, MD, George M. Hoffman,

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

How do we follow up our patients

Crane technique with the vacuum bell device for improving access in the Nuss procedure Hany Elsayed, FRCS Cth The Journal of Thoracic and Cardiovascular.

Presentation transcript:

Long-term outcomes of patients bridged to recovery versus patients bridged to transplantation Emma J. Birks, FRCP, PhD, Robert S. George, MRCS, Ashi Firouzi, RN, Gavin Wright, FRCA, Toufan Bahrami, FRCS, Magdi H. Yacoub, FRS, Asghar Khaghani, FRCS The Journal of Thoracic and Cardiovascular Surgery Volume 144, Issue 1, Pages 190-196 (July 2012) DOI: 10.1016/j.jtcvs.2012.03.021 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Diagnoses at implantation in bridge to recovery (BTR) vs bridge to transplantation (BTT) group. DCM, Dilated cardiomyopathy; IHD, ischemic heart disease; HOCM, hyperobstructive cardiomyopathy; ARVD, arrythmogenic right ventricular dysplasia; VSD, ventricular septal device. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 190-196DOI: (10.1016/j.jtcvs.2012.03.021) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Actuarial survival of explanted (n = 40) compared with transplanted (n = 52) groups. BTR, Bridge to recovery; BTT, bridge to transplant. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 190-196DOI: (10.1016/j.jtcvs.2012.03.021) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 A, Freedom from death or transplantation for explanted (n = 40) compared with death or need for ventricular assist device (VAD) support for transplanted (n = 52) group. B, Freedom from death or transplantation for explanted (n = 40) compared with death or need for VAD support for transplanted (n = 52) group, excluding noncardiac death (ie, excluding deaths from lung carcinoma and paracetemol overdose in the bridge to recovery [BTR] group and from motor neuron disease in the bridge to transplantation [BTT] group). NS, Not significant. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 190-196DOI: (10.1016/j.jtcvs.2012.03.021) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions